The document is a group presentation for an MBA course summarizing the success story of Gujarati entrepreneurs. It discusses how Gujaratis have a strong culture of entrepreneurship dating back 2000 years, and lists reasons for their business success including always having business on their mind, taking risks, and having a strong community. It then profiles several successful Gujarati entrepreneurs including Dilip Shanghvi who founded Sun Pharmaceuticals, Uday Kotak who founded Kotak Mahindra Bank, Azim Premji who led Wipro, Pankaj Patel who leads Zydus Cadila, and Gautam Adani who founded the Adani Group.

1. Entrepreneurship(ENT)
Group Presentation
Course name:- Master in business Administration
Semester:- 2
Topic Tittle: - Success story of Gujarati entrepreneurs
Division:- B
Group Members Name:-
1. Vishwa Thakkar (40)
2. Jainam shah (19)
3. Smit shah (28)
4. Disha Soneji (54)
5. Yushi Jain (50)
Submitted to :- Dr Lucky Mishra

2. Top entrepreneurs:

3.  Gujaratis are born entrepreneur:
 Did you know that Gujarat’s Businessman makes up 9.34% of the country’s creamy layer?
 Gujaratis seem to be among the most dominant communities when it comes to wealth creation. Gujarati
means Business.
 They are fond of doing business and loves to extend it at new Level. Now Why Gujrati are strong enough
in doing Business?
 If we go back 2000 years You will find the evidence of Gujarati merchants trading with the Mediterranean
and Arab nations or Empires. Ahmedabad in Gujarat, is known as the land of millionaires. Where people
are speaking the language of Business.
 Not only special any Community but all caste and people are busy in doing business. A much successful
businessman like Ambanis, Adanis hail from this land.
 Gujrati is keen on the Business management. They strictly follow the first and most important principle of
business that is, “Do not let ever any emotions control money-related decisions.

4.  Reasons Why Gujaratis Are The Best Businessmen Both In & Outside India
• Most Gujaratis Have “Business” On Their Mind Always.
• Gujaratis Are The Real Risk-Takers.
• No Job Is Small For Them.
• They Evolve with time.
• Gujaratis Have A great Sense Of Community.

5. Dilip shanghvi
Born: 1st October 1955 at Amreli, Gujarat.
Education: schooling from J.J Ajmera high
school and bachelor degree from University of
Kolkata.
Founder: SUN PHARMACEUTICALS.
Honour: Awarded by Padma Shri.
8th most powerful person of India in 2017.
His annual revenue is USD 4.5 billion.
In Forbes list he has 203 rank in 2021
HE is 9th richest man of India with net worth USD 10.9 billion.

6.  Entrepreneurial Journey:-
• Start up of sun pharamaceutical industry
• Establish new product line in his filed
• In 1994 the company went to public
• Acquired national and international companies
• His leadership in his group

7.  Introduction of sun pharama:
• Sun Pharmaceutical Industries ltd.(Sun pharma) is the fourth largest specialty generic Pharmaceutical
company in the world with global revenues of over USD4.5billion. Supported by more than 40
manufacturing facilities, they provide high-quality, affordable medicines, trusted by healthcare professionals
and patients, to more than 100 countries across the globe.
• The company was founded in 1983,38 years ago.
• Headquaters is in Mumbai Maharashtra.
• Operating income: Rs 50.10 billion.
• Revenue: Rs 334.73 billion.
• Net income: Rs 37.65 billion.
• Total assets: Rs 682.52 billion.
• Total equity: Rs 491.25 billion.
• It has 36000+ emoloyees across globe.

8.  National and international contribution:
• In the fiscal year 2020, Sun Pharmaceutical Industries generated a profit of of approximately 41 billion Indian
rupees after taxes. This was a significant increase compared to the previous year indicating a healthy growth
for the company. Sun Pharmaceutical Industries is a Indian pharmaceutical company that sells and
manufactures formulations and ingredients primarily across India and the United States.
• The drug maker's revenue from operations grew by 13 per cent to Rs 32,325 crore as compared to Rs 28,686
crore in the corresponding quarter.
• Consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) rose by 34 percent to Rs
1,363 crore and margin expanded by 250 basis points to 16.7 per cent.
• Sales in the US were at $1,487 million recording a marginal decline of 2 per cent over same period last year.
For FY20, sales in emergeing markets were at $776 million, up by 1 per cent over same period last year.
• Sun Pharma's board has recommended payment of final dividend of Rs 1 per equity share of Rs 1 each for the
year ended March 31, 2020.
• Sun Pharmaceutical Industries Ltd has committed to donate Rs 25 crore worth of Hydroxychloroquine
(HCQS), Azithromycin, other related drugs and hand sanitisers to support India's fight against coronavirus
pandemic, according to a company statement.

9. CSR of Sun Pharma:-
CSR Financial Details (INR CR)
 CSR Budget for FY 2020-21: INR 28.35 CR.
 Projects of CSR
year 2019-20 2018-19 2017-18
Actual CSR 4.37 CR 3.94 CR 2.70 CR
Prescribe CSR 2.69 CR 0.00 0.00
Disaster Relief
Programme
Water Conservation Project Education Promotion

10. • Born March 1959 (Mumbai)
• Raised in an upper middle class
Gujarati joint family.
• Bachelor’s degree and
postgraduate degree in
management studies.
• On 22 March 2003 it became the
first company in India’s corporate
history to receive a banking license
from Reserve Bank Of India.
An Indian Billionaire banker and the Executive vice-chairman
and managing director.
INTRODUCTION
• Born March 1959 (Mumbai)
• Raised in an upper middle class
Gujarati joint family.
• Bachelor’s degree and postgraduate
degree in management studies.
• On 22 March 2003 it became the first
company in India’s corporate history
to receive a banking license from
Reserve Bank Of India.

11. UDAY KOTAK’S REVIEW TOWARDS
INDIAN ECONOMY
• The current account-savings account ratio stood at 52.5
percent as of March 2019 against 50.8 percent a year ago.
• Focus on retail deposits, particularly deposits below Rs 1
crore, continues. Such deposits grew 30 percent year-on-
year.
• Witnesses an opportunity to gain market share.
• Committed to the broader financial services business,
including life insurance and asset management.
• Growth in embedded value of life insurance business stood
at Rs 7,300 crore against Rs 5,800 crore. Lower financial risk
but high franchise value businesses.
• Embracing the new world of digital, analytics, artificial
intelligence and technology.Constantly exploring new
opportunities.

13. • Born 24 July 1945 (Mumbai)
• Raised in a Shia Muslim family with
roots from Kutch in Gujarat.
• Bachelor of Science in Electrical
Engineering Degree from Stanford
University.
• Informally known as the Czar of the
Indian IT Industry.
• Premji started with a $2.2 billion
donation to the Azim Premji
Foundation, focused on education
in India.
• Emerge as one of the global
leaders in the software industry.
An Indian business tycoon, investor, engineer,
philanthropist and Chairman of Wipro Limited.
Azim Premji
Introduction:

14. AZIM PREMJI’S CONTRIBUTION TOWARDS INDIAN ECONOMY
• 2019 Wipro and University of Oulu signed memorandum
of understanding (MoU) to collaborate on 5G/6G
Technologies.
• Wipro partnered with Moogsoft to deliver next-gen AIOps
solutions.
• 2018 Recorded total income of Rs 471,896 crore (US$
7.32 billion) in FY18.
• 2017 Launched new brand identity.
• 2015 Launched 'Wipro Digital'. Key capabilities acquired
through DesignIt & Appirio.
• 2000 Listed on NYSE and enters the BPO business.
• 1990 Entered into third party R&D service and IT
services.
• 1982 Entry into IT Products.
• Become first Indian who participated in the Giving Pledge.

16. Pankaj Ramanbhai Patel
• Introduction :-
o Born :-March 16, 1953 (age 68) Bhadran
o Education:-Bachelor of Pharmacy and Master of Pharmacy from Gujarat University and Bachelor of Arts in
Science and Law from the University of Mumbai.
o Known for President, FICCI
o Chairman, Zydus
o Net worth US$6.9 billion (May 2021)
o Awards won and Achievements of Pankaj Ramanbhai Patel
Mr. Pankaj Patel was declared the Pharma Man of the Year, 2004.
The World Pharmaceutical Frontiers ranked him in their First Pharma 40 list of world's most influential people in
the field of healthcare.

17. • Entrepreneur Journey :-
• Cadila Laboratories founded by his father Ramanbhai Patel along with Indravadan Modi in 1953. Since
Pankajbhai was 8 years old, he would go to the factory with his father and would watch employees working on
tablets machines. It is believed that Pankajbhai may have decided to become a pharmacist ever since
• Pankajbhai Patel joined Cadila Laboratories in the year 1976. When he took over the Cadila Healthcare.

18. • Introduction of Zydas cadiala :-
• Ramanbhai Patel, father of Pankaj Patel founded Cadila Laboratories in 1952. He
was a lecturer in the L.M. College of Pharmacy, and started Cadila in partnership
with Shri Indravadan Modi.
• Over the next four decades, they saw the company rise into one of India's most
established pharmaceutical companies.
• Zydus Cadila is the 5th largest pharmaceutical company in India.
• Both partners agreed to share the name-Cadila for their individual groups, namely
Cadila Healthcare and Cadila Pharmaceuticals.
• Today, Pankaj enjoys 75% stake in listed flagship Cadila Health care and makes
branded and generic drugs and rabies vaccines.
• Its headquarters are located in Ahmedabad, Gujarat.
• Under Pankaj's leadership, the company has risen to being the fifth largest
pharmaceutical company in India.

19. • National and international Contribution:-
• Pankaj R Patel has made commendable contributions to the world, in the field of health care.
• The group has made significant discoveries in fields of health, such as manufacturing a drug named Roserin which
reduced the cost of treating TB by 33%.
• The Cadila Healthcare group's Zydus Wellness makes Sugar Free, the nation's most selling substitute for sugar.
• Zydas Cadila was first Indian Company to come up with H1N1 Swineflu Vaccine.
• Zydas War Against Covid-19:-
Zydus to manufacture “COVID KAVACH ELISA” - the first batch of 30,000 COVID KAVACH ELISA tests were
manufactured and supplied by Zydus, to Indian Council of Medical Research (ICMR), free of cost.
Zydus launches Immunity Booster CIMUNE, combination of Vitamin C
Oxford University trial indicates that Dexamethasone may reduce deaths by upto one third in hospitalised patients
with severe respiratory complications of COVID-19. Zydus is one of India’s leading manufacturers of
Dexamethasone.
Made Remdac (Remdesivir) made affordable at Rs. 899 (Priced Rs 2800 or 100 mg earlier)
India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D This could also be India's first
vaccine for children aged 12 years and above as the company has conducted trials on the age group.

20. • CSR:-
• Swasthya-Programmes for Health, Safety and Environment
• Shiksha and Shodh-Programmes for Education, knowledge enhancement and research
• Saath-Social care, concern and outreach programmers in times of emergencies

21. GAUTAM ADANI
 Gautam Shantilal Adani (born 24
June 1962 in a Jain family to
Shantilal and Shanti Adani
in Ahmedabad) is an Indian
billionaire industrialist
 Who is the chairman and founder
of the Adani Group -- an
Ahmedabad-based multinational
conglomerate involved in port
development and operations in
India. Adani is the president of the
Adani Foundation, which is
primarily led by his wife, Priti
Adani.
• Adani is a college dropout, who spurned his father's textile shop to set up a commodities export firm in 1988.
• Adani survived the terrorist attack in Mumbai's Taj Mahal Palace Hotel in 2008.

22. ABOUT ADANI GROUP:
REAL TIME NET WORTH OF ADANI
$69.8B
as of 6/15/21
$742 M | 1.05%
Reflects change since 5 PM ET of prior
trading day
ABOUT ADANI GROUP:
 Adani group is an Indian multinational
conglomerate, headquartered in Ahmedabad,
Gujarat, India. It was founded by
Gautam Adani in 1988 as a commodity trading
business, with the flagship
company Adani Enterprises Limited
(previously Adani Exports Limited).
 The Group's diverse businesses include
energy, resources, logistics, agribusiness, real
estate, financial services, defence and
aerospace. The group has annual revenue of
over US$13 billion with operations at 70
locations in 50 countries. It is India's largest
port developer and operator with ten ports and
terminals including Mundra Port, its largest.

23.  According to Forbes, his family's net worth
is estimated to be around US$76 billion as
of 3 June 2021.
 He is the second richest man in Asia and
13th richest man in the world according to
Forbes , a spot attained in 2021.
 As of 2018 he had a 66% stake in Adani
Ports & SEZ, 75% stake in Adani
Enterprises, 73% stake in Adani Power, and
a 75% stake in Adani Transmission.
CONTRIBUTION IN ECONOMY:

24. ADANI GROUP:
• Group invests about 2% of its total
profit in various CSR initiatives
through Adani Foundation. By
responding to the emerging needs at
grassroots level, its teams are focused
on aligning all activities with the
global Sustainable Development
Goals, striving to secure a hopeful
future for millions.

25. PROJECTS BY ADANI:

26. Thank you